$ 350.25 million Recombinant Non-Glycosylated Proteins Market is Likely to grow at 7.33% CAGR during the Period of 2028
Recombinant non-glycosylated proteins contain human colony-stimulating granulocyte factor. The recombinant non-glycosylated proteins further contain growth hormones, insulin and interferon which make them suitable for a wide range of applications. ·      Upsurge in the prevalence of chronic diseases among the population is one of the major factors...
0 Commentarii 0 Distribuiri 890 Views 0 previzualizare